South Korea vs Small Island Developing States (SIDS): Proportion of the target population … measles-containing-vaccine
South Korea
96.0%
in 2024
Small Island Developing States (SIDS)
63.0%
in 2024
South Korea rank
28th
Small Island Developing States (SIDS) rank
29th
Proportion of the target population … measles-containing-vaccine over time
- South Korea
- Small Island Developing States (SIDS)
How they compare
South Korea currently reports 96.0% against 63.0% in Small Island Developing States (SIDS), a difference of 33.0%.
That makes South Korea's figure about 1.5 times Small Island Developing States (SIDS)'s.
Across all 25 years both countries report, South Korea has been ahead every year.
South Korea ranks 28th and Small Island Developing States (SIDS) ranks 29th of 195 countries.
South Korea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South Korea | Small Island Developing States (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.0% | 19.6% | 69.4% | South Korea |
| 2010s | 96.8% | 31.6% | 65.2% | South Korea |
| 2020s | 95.4% | 56.8% | 38.6% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, South Korea or Small Island Developing States (SIDS)?
- South Korea, at 96.0% against 63.0% in Small Island Developing States (SIDS) as of 2024.
- What is the difference in proportion of the target population who received between South Korea and Small Island Developing States (SIDS)?
- 33.0%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Small Island Developing States (SIDS)?
- 25 years are reported by both, from 2000 to 2024.
- How do South Korea and Small Island Developing States (SIDS) rank globally for proportion of the target population who received?
- South Korea ranks 28th and Small Island Developing States (SIDS) ranks 29th of 195 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.